This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ entacapone,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Parkinson's Disease Management: Entacapone is primarily used as an adjunctive treatment for Parkinson's disease. It works by inhibiting the enzyme catechol-O-methyltransferase (COMT), which breaks down levodopa, allowing levodopa to remain active in the brain for a longer duration. This can help reduce the fluctuations in motor function that are often seen in Parkinson's disease patients taking levodopa/carbidopa therapy alone.

  2. Reduction of Motor Fluctuations: Parkinson's disease is characterized by motor fluctuations, including "on-off" periods and dyskinesias (abnormal involuntary movements), which can occur as the effects of levodopa wear off between doses. Entacapone helps to smooth out these fluctuations by prolonging the duration of levodopa's therapeutic effect, thereby reducing the frequency and severity of motor fluctuations.

  3. Improved Symptom Control: By enhancing the availability of levodopa in the brain, entacapone can lead to better control of Parkinson's disease symptoms such as tremor, rigidity, bradykinesia (slowness of movement), and postural instability.

  4. Dosage and Administration: Entacapone is typically taken orally in combination with levodopa and carbidopa. The dosage and frequency of administration vary depending on the individual patient's needs and response to treatment. It is usually taken with each dose of levodopa/carbidopa, but the exact timing and dosage should be determined by a healthcare professional.

  5. Side Effects: Common side effects of entacapone include diarrhea, nausea, abdominal pain, dyskinesias, dizziness, and orthostatic hypotension (a drop in blood pressure upon standing). These side effects are usually mild to moderate in severity and often resolve with continued use or dose adjustment. However, in rare cases, entacapone may cause more serious side effects such as hepatotoxicity (liver damage) or neuroleptic malignant syndrome (a potentially life-threatening condition characterized by fever, altered mental status, and muscle rigidity).

  6. Drug Interactions: Entacapone may interact with other medications, particularly those that are metabolized by the same liver enzymes or that affect dopamine levels in the brain. It is important for healthcare providers to review the patient's complete medication regimen to identify and manage potential drug interactions.

  7. Monitoring: Patients taking entacapone should be monitored regularly for both therapeutic efficacy and potential adverse effects. This may involve assessments of motor function, gastrointestinal symptoms, liver function tests, and other relevant parameters.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of entacapone,(prescription) On Probiotics

Rank Probiotic Impact
genus Bacillus Reduces
species Anaerobutyricum hallii Reduces
species Bacteroides uniformis Reduces
species Blautia hansenii Reduces
species Blautia wexlerae Reduces
species Christensenella minuta Reduces
species Enterococcus faecium Reduces
species Faecalibacterium prausnitzii Reduces
species Lactococcus cremoris Reduces
species Lactococcus lactis Reduces
species Parabacteroides distasonis Reduces

Bacteria Impacted by entacapone,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

πŸ““ Direct Citations πŸ‘ͺπŸ‘Ά Indirect Citations Taxonomy Rank Effect
0 1 Blautia genus Decreases
0 1 Enterocloster genus Decreases
0 1 Dorea genus Decreases
0 1 Ruminococcus genus Decreases
0 1 Coprococcus genus Decreases
0 1 Fusobacterium genus Decreases
0 1 Lachnospira genus Decreases
0 1 Phocaeicola genus Decreases
0 1 Collinsella genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Roseburia genus Decreases
0 1 Segatella genus Decreases
0 1 Agathobacter genus Decreases
0 1 Odoribacter genus Decreases
0 1 Clostridium genus Decreases
0 1 Clostridioides genus Decreases
0 1 Bacteroides genus Decreases
0 1 Lacrimispora genus Decreases
0 1 Bilophila genus Decreases
0 1 Parolsenella genus Decreases
0 1 Flavonifractor genus Decreases
0 1 Pseudobutyrivibrio genus Decreases
0 1 Anaerobutyricum genus Decreases
0 1 Wansuia genus Decreases
0 1 Wujia genus Decreases
0 1 Butyrivibrio genus Decreases
0 1 Subdoligranulum genus Decreases
0 1 Komagataeibacter genus Decreases
0 1 Olsenella genus Decreases
0 1 Simiaoa genus Decreases
0 1 Intestinibaculum genus Decreases
0 1 Catenibacterium genus Decreases
0 1 Faecalitalea genus Decreases
0 1 Ligilactobacillus genus Decreases
0 1 Anaerostipes genus Decreases
0 1 Christensenella genus Decreases
0 1 Massilistercora genus Decreases
0 1 Faecalibacillus genus Decreases
0 1 Eubacterium genus Decreases
0 1 Qiania genus Decreases
0 1 Treponema genus Decreases
0 1 Lachnoanaerobaculum genus Decreases
0 1 Novisyntrophococcus genus Decreases
0 1 Maliibacterium genus Decreases
0 1 Adlercreutzia genus Decreases
0 1 Lactococcus genus Decreases
0 1 Coprobacter genus Decreases
0 1 Fannyhessea genus Decreases
0 1 Marvinbryantia genus Decreases
0 1 Bacillus genus Decreases
0 1 Lachnoclostridium genus Decreases
0 1 Faecalibaculum genus Decreases
0 1 Monoglobus genus Decreases
0 1 Faecalibacterium genus Decreases
0 1 Prevotella genus Decreases
0 1 Longicatena genus Decreases
0 1 Vescimonas genus Decreases
0 1 Mageeibacillus genus Decreases
0 1 Oscillibacter genus Decreases
0 1 Leyella genus Decreases
0 1 Phoenicibacter genus Decreases
0 1 Leuconostoc genus Decreases
0 1 Parvimonas genus Decreases
0 1 Allocoprobacillus genus Decreases
0 1 Butyricicoccus genus Decreases
0 1 Parabacteroides genus Decreases
0 1 Clostridium perfringens A no rank Decreases
0 1 Clostridium perfringens B no rank Decreases
0 1 Clostridium perfringens C no rank Decreases
0 1 Clostridium perfringens CPE no rank Decreases
0 1 Clostridium perfringens D no rank Decreases
0 1 Clostridium perfringens E no rank Decreases
1 0 Lacrimispora saccharolytica species Decreases
1 0 Bacteroides xylanisolvens species Decreases
1 0 Bilophila wadsworthia species Decreases
1 0 [Ruminococcus] torques species Decreases
1 0 Agathobacter rectalis species Decreases
1 0 Bacteroides thetaiotaomicron species Decreases
1 0 Bacteroides uniformis species Decreases
1 0 Blautia obeum species Decreases
1 0 Clostridioides difficile species Decreases
1 0 Clostridium perfringens species Decreases
1 0 Collinsella aerofaciens species Decreases
1 0 Coprococcus comes species Decreases
1 0 Dorea formicigenerans species Decreases
1 0 Enterocloster bolteae species Decreases
1 0 Fusobacterium nucleatum species Decreases
1 0 Lachnospira eligens species Decreases
1 0 Mediterraneibacter gnavus species Decreases
1 0 Odoribacter splanchnicus species Decreases
1 0 Phocaeicola vulgatus species Decreases
1 0 Roseburia intestinalis species Decreases
1 0 Ruminococcus bromii species Decreases
1 0 Segatella copri species Decreases
1 0 Bacteroides fragilis species Decreases
1 0 Bacteroides caccae species Decreases
0 1 Parolsenella catena species Decreases
0 1 Coprococcus catus species Decreases
0 1 Dorea longicatena species Decreases
0 1 Anaerobutyricum hallii species Decreases
0 1 Segatella bryantii species Decreases
0 1 Bacteroides sp. CACC 737 species Decreases
0 1 Blautia sp. SC05B48 species Decreases
0 1 Wansuia hejianensis species Decreases
0 1 Komagataeibacter oboediens species Decreases
0 1 Ligilactobacillus ruminis species Decreases
0 1 Butyrivibrio crossotus species Decreases
0 1 Roseburia rectibacter species Decreases
0 1 Subdoligranulum variabile species Decreases
0 1 Eubacterium ventriosum species Decreases
0 1 Bacteroides luhongzhouii species Decreases
0 1 Clostridium sp. M62/1 species Decreases
0 1 Blautia liquoris species Decreases
0 1 Clostridium sp. SY8519 species Decreases
0 1 Faecalibacillus intestinalis species Decreases
0 1 Pseudobutyrivibrio xylanivorans species Decreases
0 1 Bacteroides humanifaecis species Decreases
0 1 Christensenella minuta species Decreases
0 1 [Ruminococcus] lactaris species Decreases
0 1 Adlercreutzia equolifaciens species Decreases
0 1 Faecalitalea cylindroides species Decreases
0 1 Intestinibaculum porci species Decreases
0 1 Parolsenella massiliensis species Decreases
0 1 Eubacterium sp. MSJ-33 species Decreases
0 1 Novisyntrophococcus fermenticellae species Decreases
0 1 Faecalibacterium duncaniae species Decreases
0 1 Qiania dongpingensis species Decreases
0 1 Massilistercora timonensis species Decreases
0 1 Bacteroides sp. A1C1 species Decreases
0 1 Anaerostipes hadrus species Decreases
0 1 Bacillus paralicheniformis species Decreases
0 1 Coprococcus eutactus species Decreases
0 1 Bacteroides sp. DH3716P species Decreases
0 1 Flavonifractor plautii species Decreases
0 1 Lachnoanaerobaculum gingivalis species Decreases
0 1 Maliibacterium massiliense species Decreases
0 1 Fannyhessea vaginae species Decreases
0 1 Wujia chipingensis species Decreases
0 1 Blautia argi species Decreases
0 1 Collinsella stercoris species Decreases
0 1 Catenibacterium mitsuokai species Decreases
0 1 [Clostridium] hylemonae species Decreases
0 1 Bacteroides sp. HF-162 species Decreases
0 1 Longicatena caecimuris species Decreases
0 1 Blautia parvula species Decreases
0 1 Ruminococcus gauvreauii species Decreases
1 0 Parabacteroides merdae species Decreases
0 1 Roseburia hominis species Decreases
0 1 Faecalibacterium sp. I2-3-92 species Decreases
0 1 Vescimonas fastidiosa species Decreases
0 1 Marvinbryantia formatexigens species Decreases
0 1 Bacteroides faecium species Decreases
0 1 Lactococcus cremoris species Decreases
0 1 Leyella stercorea species Decreases
0 1 Coprococcus sp. ART55/1 species Decreases
0 1 Streptococcus suis species Decreases
0 1 Faecalibacterium sp. IP-3-29 species Decreases
0 1 Lachnoclostridium phocaeense species Decreases
0 1 Catenibacterium sp. co_0103 species Decreases
0 1 Actinomyces oris species Decreases
0 1 Clostridium cadaveris species Decreases
0 1 Enterocloster clostridioformis species Decreases
0 1 Actinomyces naeslundii species Decreases
0 1 Faecalibacterium sp. I4-1-79 species Decreases
0 1 Alistipes sp. dk3624 species Decreases
0 1 Ruminococcus champanellensis species Decreases
0 1 uncultured Alistipes sp. species Decreases
0 1 Alistipes megaguti species Decreases
0 1 Parvimonas micra species Decreases
0 1 Treponema peruense species Decreases
0 1 Ruminococcus bicirculans (ex Wegman et al. 2014) species Decreases
0 1 Blautia wexlerae species Decreases
0 1 Faecalibacterium sp. HTF-F species Decreases
0 1 Mogibacterium diversum species Decreases
0 1 Olsenella sp. oral taxon 807 species Decreases
0 1 Adlercreutzia hattorii species Decreases
0 1 Faecalibacterium sp. I3-3-89 species Decreases
0 1 Hungatella hathewayi species Decreases
0 1 Eubacterium sp. c-25 species Decreases
0 1 Simiaoa sunii species Decreases
0 1 Treponema denticola species Decreases
0 1 Faecalibacterium sp. I4-3-84 species Decreases
0 1 Monoglobus pectinilyticus species Decreases
0 1 Faecalibacterium sp. I3-3-33 species Decreases
0 1 Corynebacterium durum species Decreases
0 1 Mageeibacillus indolicus species Decreases
0 1 Vescimonas coprocola species Decreases
0 1 Eubacterium limosum species Decreases
0 1 Prevotella intermedia species Decreases
0 1 Solibaculum mannosilyticum species Decreases
0 1 Faecalibaculum rodentium species Decreases
0 1 Faecalibacterium sp. IP-1-18 species Decreases
0 1 Coprobacter fastidiosus species Decreases
0 1 Acutalibacter muris species Decreases
0 1 [Eubacterium] hominis species Decreases
0 1 Bacteroides caecimuris species Decreases
0 1 Enterococcus faecium species Decreases
0 1 Romboutsia ilealis species Decreases
0 1 Eubacterium callanderi species Decreases
0 1 Enterococcus cecorum species Decreases
0 1 Leyella lascolaii species Decreases
0 1 Anaerostipes caccae species Decreases
0 1 Alistipes ihumii species Decreases
0 1 Oscillibacter hominis species Decreases
0 1 Phoenicibacter congonensis species Decreases
0 1 Barnesiella viscericola species Decreases
0 1 Ruminococcus bovis species Decreases
0 1 Phascolarctobacterium succinatutens species Decreases
0 1 Ruminococcus albus species Decreases
0 1 Alistipes dispar species Decreases
0 1 Butyricicoccus sp. GAM44 species Decreases
0 1 Flintibacter sp. KGMB00164 species Decreases
0 1 Parafannyhessea umbonata species Decreases
0 1 Emergencia timonensis species Decreases
0 1 Ruthenibacterium lactatiformans species Decreases
0 1 Chordicoccus furentiruminis species Decreases
0 1 Eubacterium maltosivorans species Decreases
0 1 Anaerotruncus colihominis species Decreases
0 1 Alistipes finegoldii species Decreases
0 1 Actinomyces sp. oral taxon 169 species Decreases
0 1 Blautia pseudococcoides species Decreases
0 1 Lawsonibacter asaccharolyticus species Decreases
0 1 Intestinimonas butyriciproducens species Decreases
0 1 Streptococcus gordonii species Decreases
0 1 Actinomyces sp. oral taxon 171 species Decreases
0 1 Bacteroides ovatus species Decreases
0 1 [Clostridium] scindens species Decreases
0 1 Paraprevotella clara species Decreases
0 1 Faecalibacterium prausnitzii species Decreases
0 1 Amedibacterium intestinale species Decreases
0 1 Prevotella bivia species Decreases
0 1 Streptococcus sanguinis species Decreases
0 1 Turicibacter bilis species Decreases
0 1 Phascolarctobacterium sp. Marseille-Q4147 species Decreases
0 1 Blautia hansenii species Decreases
0 1 Gordonibacter urolithinfaciens species Decreases
0 1 Pusillibacter faecalis species Decreases
0 1 Butyrivibrio fibrisolvens species Decreases
0 1 Clostridium sp. C1 species Decreases
0 1 Bacteroides sp. D2 species Decreases
0 1 Romboutsia sp. 13368 species Decreases
0 1 Blautia producta species Decreases
1 0 Parabacteroides distasonis species Decreases
0 1 Streptococcus mutans species Decreases
0 1 Alistipes communis species Decreases
0 1 Alistipes indistinctus species Decreases
0 1 Butyricimonas virosa species Decreases
0 1 Bacteroides nordii species Decreases
0 1 Alistipes senegalensis species Decreases
0 1 Alistipes onderdonkii species Decreases
0 1 Alistipes shahii species Decreases
0 1 Arabiibacter massiliensis species Decreases
0 1 Lactococcus lactis species Decreases
0 1 Prevotella dentalis species Decreases
0 1 Thomasclavelia ramosa species Decreases
0 1 Fusobacterium nucleatum subsp. nucleatum subspecies Decreases

Impact of entacapone,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 1.1 1.1
Acne 0.1 -0.1
ADHD 3.3 1.2 1.75
Age-Related Macular Degeneration and Glaucoma 1.2 0.1 11
Allergic Rhinitis (Hay Fever) 2.8 0.4 6
Allergies 5.7 3.5 0.63
Allergy to milk products 2.7 0.6 3.5
Alopecia (Hair Loss) 2 0.1 19
Alzheimer's disease 7.4 8.7 -0.18
Amyotrophic lateral sclerosis (ALS) Motor Neuron 2.9 0.7 3.14
Ankylosing spondylitis 3.6 2.7 0.33
Anorexia Nervosa 1.5 4.5 -2
Antiphospholipid syndrome (APS) 1.2 0.3 3
Asthma 4.6 1.4 2.29
Atherosclerosis 3 2.3 0.3
Atrial fibrillation 4.2 2.5 0.68
Autism 10.9 9.2 0.18
Autoimmune Disease 0.1 1 -9
Barrett esophagus cancer 0.5 0.5
benign prostatic hyperplasia 0.4 -0.4
Biofilm 1.4 1.4
Bipolar Disorder 2.4 1.7 0.41
Brain Trauma 0.8 1.8 -1.25
Breast Cancer 0.7 0.7
Cancer (General) 1 1.2 -0.2
Carcinoma 5.3 3.5 0.51
Celiac Disease 2.7 3.7 -0.37
Cerebral Palsy 0.9 2.2 -1.44
Chronic Fatigue Syndrome 6 7.5 -0.25
Chronic Kidney Disease 4.3 4.3 0
Chronic Lyme 0.6 0.8 -0.33
Chronic Obstructive Pulmonary Disease (COPD) 1.4 2.5 -0.79
Chronic Urticaria (Hives) 0.4 1.3 -2.25
Coagulation / Micro clot triggering bacteria 0.3 2.3 -6.67
Cognitive Function 2.4 1.8 0.33
Colorectal Cancer 6.8 3.3 1.06
Constipation 1.9 1.2 0.58
Coronary artery disease 2.8 4.3 -0.54
COVID-19 8.3 14.5 -0.75
Crohn's Disease 9.9 8.7 0.14
Cushing's Syndrome (hypercortisolism) 0.9 -0.9
cystic fibrosis 1.4 -1.4
d-lactic acidosis (one form of brain fog) 0.2 0.2
deep vein thrombosis 1.9 2.1 -0.11
Denture Wearers Oral Shifts 0.8 0.8
Depression 10.2 9 0.13
Dermatomyositis 0.1 0.1
Eczema 1.7 0.9 0.89
Endometriosis 2.6 2.4 0.08
Eosinophilic Esophagitis 0.6 0.1 5
Epilepsy 3.7 1.4 1.64
erectile dysfunction 1.4 0.1 13
Fibromyalgia 3.1 3 0.03
Functional constipation / chronic idiopathic constipation 5.2 5.6 -0.08
gallstone disease (gsd) 3.3 1.2 1.75
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 2.5 1.9 0.32
Generalized anxiety disorder 2.7 1.4 0.93
giant cell arteritis 0.4 -0.4
Glioblastoma 0.1 0.4 -3
Gout 1.9 1 0.9
Graves' disease 1.5 3.2 -1.13
Gulf War Syndrome 1.4 1 0.4
Halitosis 1.9 1.9
Hashimoto's thyroiditis 4.4 2.3 0.91
Heart Failure 5.2 3.2 0.63
hemorrhagic stroke 1.2 1.2
Hidradenitis Suppurativa 1.8 1.8
High Histamine/low DAO 1.5 0.6 1.5
hypercholesterolemia (High Cholesterol) 0.9 0.2 3.5
hyperglycemia 0.2 1 -4
Hyperlipidemia (High Blood Fats) 1.1 0.7 0.57
hypersomnia 0.3 1.4 -3.67
hypertension (High Blood Pressure 4.7 6.2 -0.32
Hypothyroidism 0.5 1.6 -2.2
Hypoxia 2.1 0.1 20
IgA nephropathy (IgAN) 1.7 4.8 -1.82
Inflammatory Bowel Disease 6.9 10.8 -0.57
Insomnia 2.4 3.5 -0.46
Intelligence 1.8 1.2 0.5
Intracranial aneurysms 2 1.4 0.43
Irritable Bowel Syndrome 7 5.8 0.21
ischemic stroke 1.5 1.7 -0.13
Juvenile idiopathic arthritis 0.1 0.1 0
Liver Cirrhosis 6.8 4.8 0.42
Long COVID 8.5 10.7 -0.26
Low bone mineral density 0.1 2 -19
Lung Cancer 0.6 1.9 -2.17
Lymphoma 0.1 -0.1
Mast Cell Issues / mastitis 0.6 1.1 -0.83
ME/CFS with IBS 1.1 3.1 -1.82
ME/CFS without IBS 1.3 1.8 -0.38
membranous nephropathy 0.1 0.1
Menopause 0.4 0.7 -0.75
Metabolic Syndrome 9.4 8.3 0.13
Mood Disorders 9.8 7.1 0.38
multiple chemical sensitivity [MCS] 0.6 -0.6
Multiple Sclerosis 5.3 7.4 -0.4
Multiple system atrophy (MSA) 0.3 1 -2.33
myasthenia gravis 0.2 1.1 -4.5
neuropathic pain 2.2 -2.2
Neuropathy (all types) 0.6 1.3 -1.17
neuropsychiatric disorders (PANDAS, PANS) 0.4 0.1 3
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 6.1 5.6 0.09
NonCeliac Gluten Sensitivity 1.3 0.4 2.25
Obesity 12.1 9.1 0.33
obsessive-compulsive disorder 5.1 5 0.02
Osteoarthritis 3.2 1.4 1.29
Osteoporosis 1.8 1.9 -0.06
pancreatic cancer 1 1
Parkinson's Disease 8.4 9.3 -0.11
Polycystic ovary syndrome 6.9 3.6 0.92
Postural orthostatic tachycardia syndrome 0.5 0.6 -0.2
Premenstrual dysphoric disorder 1 0.2 4
primary biliary cholangitis 0.7 2.1 -2
Primary sclerosing cholangitis 1.4 4.1 -1.93
Psoriasis 3.2 3.1 0.03
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 9 6 0.5
Rosacea 1.3 1 0.3
Schizophrenia 6.6 4 0.65
scoliosis 0.8 1.5 -0.88
sensorineural hearing loss 0.4 0.4
Sjögren syndrome 2.1 2.9 -0.38
Sleep Apnea 2.9 2.1 0.38
Slow gastric motility / Gastroparesis 1.1 0.2 4.5
Small Intestinal Bacterial Overgrowth (SIBO) 2.1 2.1
Stress / posttraumatic stress disorder 2.5 2.2 0.14
Systemic Lupus Erythematosus 4.5 3.5 0.29
Tic Disorder 1.7 2.3 -0.35
Tourette syndrome 0.5 0.3 0.67
Type 1 Diabetes 4.1 3.5 0.17
Type 2 Diabetes 10.7 7.4 0.45
Ulcerative colitis 6.4 8.3 -0.3
Unhealthy Ageing 6.3 2.7 1.33
Vitiligo 2 1.2 0.67

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]